These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 25956355)

  • 1. Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity.
    van der Pouw Kraan TC; Chen WJ; Bunck MC; van Raalte DH; van der Zijl NJ; van Genugten RE; van Bloemendaal L; Baggen JM; Serné EH; Diamant M; Horrevoets AJ
    BMC Med Genomics; 2015 May; 8():20. PubMed ID: 25956355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiles displayed by peripheral blood mononuclear cells from patients with type 2 diabetes mellitus focusing on biological processes implicated on the pathogenesis of the disease.
    Manoel-Caetano FS; Xavier DJ; Evangelista AF; Takahashi P; Collares CV; Puthier D; Foss-Freitas MC; Foss MC; Donadi EA; Passos GA; Sakamoto-Hojo ET
    Gene; 2012 Dec; 511(2):151-60. PubMed ID: 23036710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus.
    Tsai JC; Sheu SH; Chiu HC; Chung FM; Chang DM; Chen MP; Shin SJ; Lee YJ
    Diabetes Metab Res Rev; 2007 Feb; 23(2):111-8. PubMed ID: 16703635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
    Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
    Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome.
    Phillips CM; Goumidi L; Bertrais S; Field MR; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
    J Nutr Biochem; 2012 Mar; 23(3):239-44. PubMed ID: 21543200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients.
    Pedersen L; Nybo M; Poulsen MK; Henriksen JE; Dahl J; Rasmussen LM
    BMC Cardiovasc Disord; 2014 Dec; 14():196. PubMed ID: 25527236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia.
    Jackson KG; Walden CM; Murray P; Smith AM; Minihane AM; Lovegrove JA; Williams CM
    Metabolism; 2013 Aug; 62(8):1065-9. PubMed ID: 23598085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in adult patients with Prader-Willi syndrome.
    Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
    Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
    Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of metabolic syndrome and type 2 diabetes mellitus. Results from the D.E.S.I.R. prospective cohort.
    Alessi MC; Nicaud V; Scroyen I; Lange C; Saut N; Fumeron F; Marre M; Lantieri O; Fontaine-Bisson B; Juhan-Vague I; Balkau B; Tregouet DA; Morange PE;
    Thromb Haemost; 2011 Sep; 106(3):416-22. PubMed ID: 21800006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome.
    Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L
    Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of metabolic syndrome components in adults with a healthy obese phenotype: a 3-year follow-up.
    den Engelsen C; Gorter KJ; Salomé PL; Rutten GE
    Obesity (Silver Spring); 2013 May; 21(5):1025-30. PubMed ID: 23404911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.
    Meigs JB; Wilson PW; Fox CS; Vasan RS; Nathan DM; Sullivan LM; D'Agostino RB
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2906-12. PubMed ID: 16735483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome.
    Jialal I; Devaraj S; Adams-Huet B; Chen X; Kaur H
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E1844-50. PubMed ID: 22872691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor-19 levels in type 2 diabetic patients with metabolic syndrome.
    Barutcuoglu B; Basol G; Cakir Y; Cetinkalp S; Parildar Z; Kabaroglu C; Ozmen D; Mutaf I; Bayindir O
    Ann Clin Lab Sci; 2011; 41(4):390-6. PubMed ID: 22166511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional risk and metabolic syndrome in Korean type 2 diabetes mellitus.
    Kim WY; Kim JE; Choi YJ; Huh KB
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():47-51. PubMed ID: 18296299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of N-terminal pro brain natriuretic peptide are enhanced in people with the uncomplicated metabolic syndrome: a case-cohort analysis of the population-based Casale Monferrato study.
    Bruno G; Barutta F; Landi A; Pinach S; Caropreso P; Mengozzi G; Baldassarre S; Fragapani S; Civera S; Cavallo Perin P; Gruden G
    Diabetes Metab Res Rev; 2015 May; 31(4):360-7. PubMed ID: 25370350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome.
    Shirakawa T; Nakajima K; Yatsuzuka S; Shimomura Y; Kobayashi J; Machida T; Sumino H; Murakami M
    Clin Chim Acta; 2015 Feb; 440():123-32. PubMed ID: 25445417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.